Form Bio Co. Ltd.
From Bio Co.,Ltd manufactures and sells health related products in South Korea. It offers health functional food, health beauty, and living health products. The company also provides cosmetic products under the Mastina and HYCL brands. In addition, it operates an online platform to retail its products. The company was founded in 2006 and is headquartered in Suwon-si, South Korea.
Form Bio Co. Ltd. (377220) - Total Liabilities
Latest total liabilities as of September 2025: ₩38.97 Billion KRW
Based on the latest financial reports, Form Bio Co. Ltd. (377220) has total liabilities worth ₩38.97 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Form Bio Co. Ltd. - Total Liabilities Trend (2019–2024)
This chart illustrates how Form Bio Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Form Bio Co. Ltd. Competitors by Total Liabilities
The table below lists competitors of Form Bio Co. Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
SCI Information Service Inc
KQ:036120
|
Korea | ₩5.67 Billion |
|
Proximar Seafood AS
OL:PROXI
|
Norway | Nkr1.35 Billion |
|
Western Energy Services Corp
PINK:WEEEF
|
USA | $118.42 Million |
|
Inzi Display Co.Ltd
KQ:037330
|
Korea | ₩311.76 Billion |
|
Midsummer AB (publ)
ST:MIDS
|
Sweden | Skr313.58 Million |
|
Bakrie Sumatera Plantations
JK:UNSP
|
Indonesia | Rp8.59 Trillion |
|
Next Entertainment World Co. Ltd
KQ:160550
|
Korea | ₩128.06 Billion |
|
Paru Co. Ltd
KQ:043200
|
Korea | ₩33.70 Billion |
Liability Composition Analysis (2019–2024)
This chart breaks down Form Bio Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.69 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.02 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.52 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Form Bio Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Form Bio Co. Ltd. (2019–2024)
The table below shows the annual total liabilities of Form Bio Co. Ltd. from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩32.07 Billion | +44.51% |
| 2023-12-31 | ₩22.19 Billion | +278.22% |
| 2022-12-31 | ₩5.87 Billion | -51.05% |
| 2021-12-31 | ₩11.99 Billion | -43.86% |
| 2020-12-31 | ₩21.35 Billion | -38.02% |
| 2019-12-31 | ₩34.45 Billion | -- |